Media Thread, page-14724

@col75, clearly the message is not getting to the general public and by extension investors.
Equally clear is that Imugene are mainly concerned about gathering and presenting data at prestigious conferences, as investors we need to shift our focus on this data and not concern ourselves with the constant ups and downs of the daily/weekly shareprice.
Leslie has always maintained as has Jacob Dupont and others that the patients are their North Star, and why shouldn't this be their main focus, those of us who may have had cancer or had loved ones with cancer understand that this IS the only important thing.
Yes, our money has been put into this company in the hope of generating a good return, and this has been our choice, we have placed our bet and now we have to wait until data tells us if we have won the race or come in the placings.
Aside from that we have invested in what can only be described as an ethical investment with which many lives can be saved, or in the least extended.
The science is there and proven at least in animal models, time, that being over the next 2-5 years will tell us if it works safely and efficaciously in humans.
Some will not have the patience for this time-frame and will move on and I wish them all the best, 5 years is such a small time-frame in the big scheme, so I will wait it out until such time that the company takes a wrong turn that I don't wish to follow.

DYOR opinion only